Skip to main content
Chitra Hosing, MD, Oncology, Houston, TX, University of Texas M.D. Anderson Cancer Center

ChitraHosingMD

Oncology Houston, TX

Hematologic Oncology

MD

Dr. Hosing is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hosing's full profile

Already have an account?

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Hematology and Medical Oncology, 1996 - 1999
  • Westchester Medical Center
    Westchester Medical CenterResidency, Internal Medicine, 1993 - 1996
  • Lady Hardinge Medical College
    Lady Hardinge Medical CollegeClass of 1985

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • TX State Medical License
    TX State Medical License 1999 - 2026
  • TN State Medical License
    TN State Medical License 2023 - 2025
  • GA State Medical License
    GA State Medical License 2023 - 2025
  • AZ State Medical License
    AZ State Medical License 2023 - 2025
  • OK State Medical License
    OK State Medical License 2020 - 2024
  • AL State Medical License
    AL State Medical License 2023 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Pilot Study Using Post-Transplant Cyclophosphamide (PTCy), Tacrolimus and Mycophenolate GVHD Prophylaxis for Older Patients Receiving 10/10 HLA-Matched Unrelated Donor...  
    Uday R Popat, Amin Alousi, Issa F Khouri, Muzaffar Qazilbash, Richard E Champlin, Partow Kebriaei, Simrit Parmar, Chitra Hosing, Nature
  • Impact of a Novel Prognostic Model, Hematopoietic Cell Transplant-Composite Risk (HCT-CR), on Allogeneic Transplant Outcomes in Patients with Acute Myeloid Leukemia an...  
    Uday Popat, Chitra M Hosing, Issa Khouri, Richard Champlin, Simrit Parmar, Partow Kebriaei, Borje S Andersson, Qaiser Bashir, Amin Alousi, Nature
  • Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers  
    Ravi Murthy, Robert S Benjamin, Anthony P Conley, Chitra Hosing, David S Hong, Aung Naing, Clinical Cancer Research

Abstracts/Posters

  • A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS
    Chitra Hosing, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Allogeneic Hematopoietic Cell Transplantation May Improve Long-Term Outcomes in Patients with Ph-like Acute Lymphoblastic Leukemia with CRLF2 Overexpression
    Chitra Hosing, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Optimizing the Use of Platelets in a Single Oncology Center during Critical Shortages: Can Current Platelet Donations from Volunteer Donors be Sustained to Provide Ade...
    Chitra Hosing, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Hematopoietic Cell Transplant -Composite Risk (HCT-CR) - a Novel Prognostic Model to Predict Transplant Outcomes 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Outcome of Autologous Stem Cell Transplantation in Waldenström's Macroglobulinemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Hospital Affiliations